Does PALBOCICLIB Cause Urinary tract infection? 1,209 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,209 reports of Urinary tract infection have been filed in association with PALBOCICLIB (Ibrance). This represents 1.3% of all adverse event reports for PALBOCICLIB.
1,209
Reports of Urinary tract infection with PALBOCICLIB
1.3%
of all PALBOCICLIB reports
76
Deaths
519
Hospitalizations
How Dangerous Is Urinary tract infection From PALBOCICLIB?
Of the 1,209 reports, 76 (6.3%) resulted in death, 519 (42.9%) required hospitalization, and 32 (2.6%) were considered life-threatening.
Is Urinary tract infection Listed in the Official Label?
Yes, Urinary tract infection is listed as a known adverse reaction in the official FDA drug label for PALBOCICLIB.
What Other Side Effects Does PALBOCICLIB Cause?
Fatigue (15,190)
White blood cell count decreased (11,273)
Neoplasm progression (10,885)
Death (8,410)
Nausea (8,189)
Neutropenia (6,423)
Alopecia (6,201)
Diarrhoea (5,635)
Asthenia (3,660)
Off label use (3,405)
What Other Drugs Cause Urinary tract infection?
ADALIMUMAB (6,375)
LENALIDOMIDE (4,247)
ETANERCEPT (3,915)
OCRELIZUMAB (3,618)
TOFACITINIB (3,179)
METHOTREXATE (2,960)
DALFAMPRIDINE (2,757)
RITUXIMAB (2,579)
CARBIDOPA\LEVODOPA (2,151)
ABATACEPT (2,110)
Which PALBOCICLIB Alternatives Have Lower Urinary tract infection Risk?
PALBOCICLIB vs PALIPERIDONE
PALBOCICLIB vs PALIVIZUMAB
PALBOCICLIB vs PALONOSETRON
PALBOCICLIB vs PAMIDRONATE
PALBOCICLIB vs PAMIDRONIC ACID